Test Price
2,800 AED✅ Home Collection Available
IGF2 Gene Diabetes Genetic Test in Dubai, UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO‑accredited next‑generation sequencing with orthogonal Sanger confirmation for all coding exons and splice junctions of IGF2.
- Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM across all Dubai residential zones.
- Clinical Guidance: Post‑test telephonic genetic counseling provided by a DHA‑licensed consultant medical geneticist with complete result interpretation and familial risk assessment.
- Insurance Facilitation: Direct billing verification and pre‑approval handled via WhatsApp at +971 54 548 8731 for major UAE health insurers.
Test Overview & Methodology
A targeted genetic test for IGF2‑related diabetes susceptibility using next‑generation sequencing. This assay identifies pathogenic variants in the IGF2 gene implicated in metabolic disorders, enabling personalized risk assessment and early intervention strategies. The analysis covers all coding exons, intron–exon boundaries, and the promoter region with a minimum read depth of 100× and uniform coverage >95 % of target bases.
Test Comparison: Targeted IGF2 NGS vs. Whole Exome Sequencing
| Feature | IGF2 Gene NGS (Our Test) | Whole Exome Sequencing (WES) |
|---|---|---|
| Precision (diagnostic yield) | 99.9% sensitivity for IGF2 coding regions | ~25–35% for unspecific diabetes panels |
| Method | NGS + Sanger confirmation (ISO‑certified) | NGS only; often no orthogonal validation |
| Turnaround Time | 3–4 weeks | 6–12 weeks typical |
| Clinical Interpretation | Medical geneticist‑curated report with actionable metabolic insights | Broad variant list; limited metabolic focus |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403:
“Genetic testing for IGF2 variants provides valuable insight into hereditary diabetes risk, but results must always be interpreted within the full context of family history and clinical presentation. A detected variant indicates susceptibility, not certainty. I recommend all patients consult with a qualified medical geneticist or endocrinologist to develop a personalized surveillance and prevention strategy.”
Advisory – Medication & Clinical Caution
⚠️ Do Not Modify Prescribed Therapy
Never discontinue, adjust, or initiate any diabetes medication, insulin regimen, or dietary supplement based solely on genetic test results without direct consultation with your treating physician. This test does not replace routine glucose monitoring, HbA1c surveillance, or clinical evaluation.
Exclusion Criteria & Emergency Red Flags
⛔ Not for Acute or Emergency Use
- This test is not suitable for diagnosing acute metabolic emergencies such as diabetic ketoacidosis, hyperosmolar hyperglycemic state, or hypoglycemic coma.
- Blood collection must be performed by a DHA‑licensed phlebotomist using the supplied FTA card or vacutainer system; self‑collection is not permitted.
- Seek immediate emergency care if you experience confusion, fruity‑smelling breath, severe abdominal pain, or rapid breathing — these may indicate life‑threatening metabolic decompensation.
- Do not use this test to adjust insulin doses without concomitant glucose monitoring and medical supervision.
Patient FAQ & Clinical Guidance
1. What is the IGF2 Gene Diabetes NGS Test and how is it performed?
This genetic test identifies IGF2 gene mutations that increase diabetes risk using high‑accuracy next‑generation sequencing. A small blood sample drawn at home or in‑clinic, or a dried blood spot on an FTA card, is required. DNA is extracted and analyzed in our ISO‑certified laboratory to detect subtle sequence variations. Results are interpreted by a multidisciplinary team and reported within 3–4 weeks.
2. Who should consider this test and what do the results mean?
This test is ideal for individuals with a strong family history of early‑onset diabetes or unexplained metabolic syndrome features. A positive result indicates an elevated genetic predisposition; it is not a diagnosis of active disease. A negative result greatly reduces the likelihood of IGF2‑mediated diabetes but does not eliminate risk from other genes or lifestyle factors. All results should be reviewed with a diabetologist, endocrinologist, or medical geneticist to plan appropriate surveillance and preventive measures.
3. How does home collection work and what about insurance coverage?
Our DHA‑licensed mobile phlebotomists visit your home at your convenience, maintaining strict cold‑chain protocols. After booking, a trained professional arrives with the required collection kit. Your sample is immediately transferred to a temperature‑controlled transport container. For insurance, send your policy details via WhatsApp to +971 54 548 8731; we verify coverage and handle direct billing with most major insurers in the UAE.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑controlled, and processed exclusively within UAE‑based secure servers. Clinical safety and patient consent protocols adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License No. 1143 and maintains ISO 9001:2015 certification (certificate ID: INT/EGQ/2509DA/3139) for quality management in laboratory testing.
Clinical & Logistical Metadata
| Test Name | IGF2 Gene Diabetes Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | E11.9, R73.03, Z13.1 |
| LOINC Code | 10193-4 |
| DHA Facility License & Laboratory Address | DHA License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians